(Q41682341)

7 October 2017

1 reference

title

DNA cancer vaccines: a gene gun approach (English)

1 reference

7 October 2017

Mahvi DM

1

1 reference

PubMed ID

9429892

7 October 2017

Sheehy MJ

series ordinal

2

1 reference

PubMed ID

9429892

7 October 2017

Yang NS

series ordinal

3

1 reference

7 October 2017

1 October 1997

1 reference

Immunology & Cell Biology

7 October 2017

1 reference

7 October 2017

75

1 reference

7 October 2017

5

1 reference

7 October 2017

456-460

1 reference

Gene therapy for cancer: what have we done and where are we going?

7 October 2017

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.70

Development of cancer immunotherapies based on identification of the genes encoding cancer regression antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.70

Developing particle-mediated gene-transfer technology for research into gene therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.70

Major histocompatibility complex class II-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.70

Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.70

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.70

Particle-mediated gene transfer of granulocyte-macrophage colony-stimulating factor cDNA to tumor cells: implications for a clinically relevant tumor vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.70

IL-12 gene therapy using direct injection of tumors with genetically engineered autologous fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.70

Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.70

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.70

Gene gun and other non-viral approaches for cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.70

Lymphokines and cytokines as cancer treatment. Immunotherapy realized

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.70

Cancer vaccines: the interleukin 2 dosage effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.70

In vivo cytokine gene transfer by gene gun reduces tumor growth in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.70

Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.70

Combined chemokine and cytokine gene transfer enhances antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.70

7 January 2021

Repetitive weekly cycles of recombinant human interleukin-2: responses of renal carcinoma with acceptable toxicity

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.70

7 January 2021

Prolonged continuous intravenous infusion interleukin-2 and lymphokine-activated killer-cell therapy for metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.70

7 January 2021

Phase I study of non-replicating autologous tumor cell injections using cells prepared with or without GM-CSF gene transduction in patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.70

7 January 2021

Phase I/IB study of immunization with autologous tumor cells transfected with the GM-CSF gene by particle-mediated transfer in patients with melanoma or sarcoma

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.70

7 January 2021

Identifiers

DOI

10.1038/ICB.1997.70

1 reference

7 October 2017

1 reference

PubMed ID

9429892